Science | Nature | Cell | View More
Natural Products
Dehydroepiandrosterone
Dehydroepiandrosterone
ChemFaces products have been cited in many studies from excellent and top scientific journals
Product Name Dehydroepiandrosterone
Price: $40 / 20mg
CAS No.: 53-43-0
Catalog No.: CFN90043
Molecular Formula: C19H28O2
Molecular Weight: 288.42 g/mol
Purity: >=98%
Type of Compound: Steroids
Physical Desc.: Powder
Source:
Solvent: Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Download: COA    MSDS    SDF
Similar structural: Comparison (Web)  (SDF)
Guestbook:
Contact Us
Order & Inquiry & Tech Support

Tel: (0086)-27-84237683
Tech: service@chemfaces.com
Order: manager@chemfaces.com
Address: 176, CheCheng Eest Rd., WETDZ, Wuhan, Hubei 430056, PRC
How to Order
Orders via your E-mail:

1. Product number / Name / CAS No.
2. Delivery address
3. Ordering/billing address
4. Contact information
Order: manager@chemfaces.com
Delivery time
Delivery & Payment method

1. Usually delivery time: Next day delivery by 9:00 a.m. Order now

2. We accept: Wire transfer & Credit card & Paypal
Citing Use of our Products
* Packaging according to customer requirements(5mg, 10mg, 20mg and more). We shipped via FedEx, DHL, UPS, EMS and others courier.
According to end customer requirements, ChemFaces provide solvent format. This solvent format of product intended use: Signaling Inhibitors, Biological activities or Pharmacological activities.
Size /Price /Stock 10 mM * 1 mL in DMSO / $8.9 / In-stock
Other Packaging *Packaging according to customer requirements(100uL/well, 200uL/well and more), and Container use Storage Tube With Screw Cap
Our products had been exported to the following research institutions and universities, And still growing.
  • Research Unit Molecular Epigene... (Germany)
  • Semmelweis Unicersity (Hungary)
  • Monash University (Australia)
  • Shanghai Institute of Organic C... (China)
  • Uniwersytet Jagielloński w Kra... (Poland)
  • Medizinische Universit?t Wien (Austria)
  • University of Mysore (India)
  • S.N.D.T. Women's University (India)
  • Fraunhofer-Institut für Moleku... (Germany)
  • The Institute of Cancer Research (United Kingdom)
  • Universidade Federal de Goias (... (Brazil)
  • More...
Package
Featured Products
Hesperetin

Catalog No: CFN98842
CAS No: 520-33-2
Price: $40/20mg
Ononin

Catalog No: CFN99136
CAS No: 486-62-4
Price: $50/20mg
6,8-Diprenylgenistein

Catalog No: CFN97935
CAS No: 51225-28-6
Price: $ / mg
Coronaridine

Catalog No: CFN92859
CAS No: 467-77-6
Price: $ / mg
11-Oxomogroside III

Catalog No: CFN92192
CAS No: 952481-53-7
Price: $318/10mg
Piplartine

Catalog No: CFN96137
CAS No: 20069-09-4
Price: $100/20mg
Paeoniflorin

Catalog No: CFN99544
CAS No: 23180-57-6
Price: $30/20mg
Madecassic acid

Catalog No: CFN99914
CAS No: 18449-41-7
Price: $30/20mg
Alstonine

Catalog No: CFN97709
CAS No: 642-18-2
Price: $ /
Beta-mangostin

Catalog No: CFN99723
CAS No: 20931-37-7
Price: $218/10mg
Related Screening Libraries
Size /Price /Stock 10 mM * 100 uL in DMSO / Inquiry / In-stock
10 mM * 1 mL in DMSO / Inquiry / In-stock
Related Libraries
Biological Activity
Description: Dehydroepiandrosterone is an important endogenous steroid hormone, which is an androgen receptor antagonist and an estrogen receptor agonist. Dehydroepiandrosterone can treat symptoms, and signs of vulvovaginal atrophy along with libido in postmenopausal women. Dehydroepiandrosterone is a neuroactive hormone, it in co-operation with other hormones and transmitters significantly affects some aspects of human mood, and modifies some features of human emotions and behavior; it has been reported that its administration can increase feelings of well-being and is useful in ameliorating atypical depressive disorders, it has neuroprotective and antiglucocorticoid activity and modifies immune reactions.
Targets: Estrogen receptor | Progestogen receptor
In vivo:
J Steroid Biochem Mol Biol. 2015 Jan;145:254-60.
Dehydroepiandrosterone: a neuroactive steroid.[Pubmed: 24704258]
Dehydroepiandrosterone (DHEA) and its sulfate bound form (DHEAS) are important steroids of mainly adrenal origin. They are produced also in gonads and in the brain.
METHODS AND RESULTS:
Dehydroepiandrosterone easily crosses the brain-blood barrier and in part is also produced locally in the brain tissue. In the brain, DHEA exerts its effects after conversion to either testosterone and dihydrotestosterone or estradiol via androgen and estrogen receptors present in the most parts of the human brain, through mainly non-genomic mechanisms, or eventually indirectly via the effects of its metabolites formed locally in the brain. As a neuroactive hormone, DHEA in co-operation with other hormones and transmitters significantly affects some aspects of human mood, and modifies some features of human emotions and behavior. It has been reported that its administration can increase feelings of well-being and is useful in ameliorating atypical depressive disorders. It has neuroprotective and antiglucocorticoid activity and modifies immune reactions, and some authors have also reported its role in degenerative brain diseases.
CONCLUSIONS:
Here we present a short overview of the possible actions of Dehydroepiandrosterone and its sulfate in the brain, calling attention to various mechanisms of their action as neurosteroids and to prospects for the knowledge of their role in brain disorders.
J Steroid Biochem Mol Biol. 2015 Jan;145:139-43.
Dehydroepiandrosterone intra vaginal administration for the management of postmenopausal vulvovaginal atrophy.[Pubmed: 25201455]
The effects of intravaginal administration of Dehydroepiandrosterone (DHEA) for the management of symptomatic vulvovaginal atrophy are reviewed. A literature search related to vulvovaginal atrophy, vaginal atrophy, atrophic vaginitis, estrogen, Dehydroepiandrosterone, vulvar itching, burning, dryness, dyspareunia, and libido was performed. Relevant articles addressing the incidence, management, and outcome of DHEA therapy were identified and used for this Expert Opinion. DHEA compared to a placebo is an effective treatment improving symptoms of vaginal atrophy: dyspareunia, burning, itching, and dryness. Objective parameters of vaginal atrophy, specifically pH, vaginal maturation index (VMI), and investigator-evaluated changes in the vagina: moisture, epithelia integrity and color were improved compared to baseline and placebo. There were significant improvements in libido and dyspareunia with the intravaginal use of DHEA that contribute to improved quality of life for postmenopausal women.
CONCLUSIONS:
Dehydroepiandrosterone administered intravaginally on a daily basis is an effective treatment for symptoms, and signs of vulvovaginal atrophy along with libido in postmenopausal women. This article is part of a Special Issue entitled 'Essential role of DHEA'.
J Am Coll Cardiol. 2014 Oct 28;64(17):1801-10.
Dehydroepiandrosterone and its sulfate predict the 5-year risk of coronary heart disease events in elderly men.[Pubmed: 25443702]
The adrenal sex hormone Dehydroepiandrosterone (DHEA), which is present in serum mainly as the sulfate DHEA-S, is the most abundant steroid hormone in human blood. Its levels decline dramatically with age. Despite the great amount of literature on vascular and metabolic actions of DHEA/-S, evidence for an association between DHEA/-S levels and cardiovascular events is contradictory. This study tested the hypothesis that serum DHEA and DHEA-S are predictors of major coronary heart disease (CHD) and/or cerebrovascular disease (CBD) events in a large cohort of elderly men.
METHODS AND RESULTS:
We used gas and liquid chromatography-mass spectrometry to analyze baseline levels of DHEA and DHEA-S in the prospective population-based Osteoporotic Fractures in Men study in Sweden (2,416 men, ages 69 to 81 years). Complete cardiovascular clinical outcomes were available from national Swedish registers. During the 5-year follow-up, 302 participants experienced a CHD event, and 225 had a CBD event. Both DHEA and DHEA-S levels were inversely associated with the age-adjusted risk of a CHD event; the hazard ratios and 95% confidence intervals per SD increase were 0.82 (0.73 to 0.93) and 0.86 (0.77 to 0.97), respectively. In contrast, DHEA/-S showed no statistically significant association with the risk of CBD events. The association between DHEA and CHD risk remained significant after adjustment for traditional cardiovascular risk factors, serum total testosterone and estradiol, C-reactive protein, and renal function, and remained unchanged after exclusion of the first 2.6 years of follow-up to reduce reverse causality.
CONCLUSIONS:
Low serum levels of DHEA and its sulfate predict an increased risk of CHD, but not CBD, events in elderly men.
Reprod Biomed Online. 2014 Jun;28(6):743-7.
Role of dehydroepiandrosterone in improving oocyte and embryo quality in IVF cycles.[Pubmed: 24745834]
The purpose of this study was to evaluate the role of Dehydroepiandrosterone (DHEA) on the number and quality of oocytes and embryos in poor responders undergoing IVF cycles.
METHODS AND RESULTS:
A total of 50 patients with a history of poor ovarian response in the previous cycle(s) were enrolled in a prospective cohort study. They were treated with oral micronized DHEA 25mg three times a day for 4 months. Oocyte and embryo number and quality were recorded before and after treatment. The results were analysed using Student's paired t-test. After treatment with DHEA, a significant increase in number of mature follicles was seen in the post treatment period (⩽ 35 years P<0.001; ⩾ 36 years P = 0.002). There were significant increases in numbers of oocytes retrieved, fertilization rates and, consequently, the total number of embryos available. More embryos were vitrified among patients ⩽ 35 years (P<0.001) post treatment, and clinical pregnancy rate in this group was 26.7%. DHEA treatment resulted in a higher number of oocytes retrieved, oocytes fertilized, embryos overall and of grade-I embryos. It can help in increasing pregnancy rate in poor responders. This study was performed to evaluate the role of Dehydroepiandrosterone (DHEA) treatment on the number and quality of oocytes and embryos in poor responders undergoing IVF cycles. Fifty patients with a history of poor ovarian response in the previous cycle(s) were enrolled in the study and a prospective cohort study was performed. Patients were prescribed oral micronized DHEA 25mg three times a day for 4 months. Oocytes and embryos in terms of both number and quality were measured before and after treatment. A significant increase in mean number of mature follicles was seen in the post-treatment group. There was a significant increase in the number of oocytes retrieved, fertilization rates and, consequently, in the total number of embryos available after treatment with DHEA. More embryos were vitrified post treatment and the overall pregnancy rate was 20%. DHEA resulted in a significant improvement in the numbers of oocytes retrieved, oocytes fertilized, embryos and grade-I embryos.
CONCLUSIONS:
DHEA can help improve pregnancy rate in poor responders with history of previous failed IVF cycles.
Dehydroepiandrosterone Description
Source:
Solvent: Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Storage: Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

After receiving: The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
ChemFaces New Products and Compounds
Arisanschinin E

Catalog No: CFN95221
CAS No: 1333378-33-8
Price: $ / mg
Lappaol F

Catalog No: CFN95069
CAS No: 69394-17-8
Price: $368/10mg
Iristectorin A

Catalog No: CFN95037
CAS No: 37744-61-9
Price: $318/20mg
2-Phenylethyl-beta-glucopyranoside

Catalog No: CFN95429
CAS No: 18997-54-1
Price: $318/10mg
Aegineoside

Catalog No: CFN95270
CAS No: 752209-48-6
Price: $413/5mg
Herbacetin 3-sophoroside-8-glucosi...

Catalog No: CFN95529
CAS No: 77298-68-1
Price: $318/5mg
Pueroside A

Catalog No: CFN95177
CAS No: 100692-52-2
Price: $318/5mg
Alloisoimperatorin

Catalog No: CFN95012
CAS No: 35214-83-6
Price: $338/5mg
Recently, ChemFaces products have been cited in many studies from excellent and top scientific journals

Cell. 2018 Jan 11;172(1-2):249-261.e12.
doi: 10.1016/j.cell.2017.12.019.
IF=36.216(2019)

PMID: 29328914

Cell Metab. 2020 Mar 3;31(3):534-548.e5.
doi: 10.1016/j.cmet.2020.01.002.
IF=22.415(2019)

PMID: 32004475

Mol Cell. 2017 Nov 16;68(4):673-685.e6.
doi: 10.1016/j.molcel.2017.10.022.
IF=14.548(2019)

PMID: 29149595

ACS Nano. 2018 Apr 24;12(4): 3385-3396.
doi: 10.1021/acsnano.7b08969.
IF=13.903(2019)

PMID: 29553709

Nature Plants. 2016 Dec 22;3: 16206.
doi: 10.1038/nplants.2016.205.
IF=13.297(2019)

PMID: 28005066

Sci Adv. 2018 Oct 24;4(10): eaat6994.
doi: 10.1126/sciadv.aat6994.
IF=12.804(2019)

PMID: 30417089
Calculate Dilution Ratios(Only for Reference)
1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 3.4672 mL 17.3358 mL 34.6717 mL 69.3433 mL 86.6791 mL
5 mM 0.6934 mL 3.4672 mL 6.9343 mL 13.8687 mL 17.3358 mL
10 mM 0.3467 mL 1.7336 mL 3.4672 mL 6.9343 mL 8.6679 mL
50 mM 0.0693 mL 0.3467 mL 0.6934 mL 1.3869 mL 1.7336 mL
100 mM 0.0347 mL 0.1734 mL 0.3467 mL 0.6934 mL 0.8668 mL
* Note: If you are in the process of experiment, it's need to make the dilution ratios of the samples. The dilution data of the sheet for your reference. Normally, it's can get a better solubility within lower of Concentrations.
Hesperetin

Catalog No: CFN98842
CAS No: 520-33-2
Price: $40/20mg
Ononin

Catalog No: CFN99136
CAS No: 486-62-4
Price: $50/20mg
6,8-Diprenylgenistein

Catalog No: CFN97935
CAS No: 51225-28-6
Price: $ / mg
Coronaridine

Catalog No: CFN92859
CAS No: 467-77-6
Price: $ / mg
11-Oxomogroside III

Catalog No: CFN92192
CAS No: 952481-53-7
Price: $318/10mg
Piplartine

Catalog No: CFN96137
CAS No: 20069-09-4
Price: $100/20mg
Paeoniflorin

Catalog No: CFN99544
CAS No: 23180-57-6
Price: $30/20mg
Madecassic acid

Catalog No: CFN99914
CAS No: 18449-41-7
Price: $30/20mg
Alstonine

Catalog No: CFN97709
CAS No: 642-18-2
Price: $ /
Beta-mangostin

Catalog No: CFN99723
CAS No: 20931-37-7
Price: $218/10mg
Tags: buy Dehydroepiandrosterone | Dehydroepiandrosterone supplier | purchase Dehydroepiandrosterone | Dehydroepiandrosterone cost | Dehydroepiandrosterone manufacturer | order Dehydroepiandrosterone | Dehydroepiandrosterone distributor